Global expansion Sirio Pharma is expanding its manufacturing footprint with a new facility in Thailand and has seven manufacturing sites across China, Germany, and the United States, signaling increased regional capacity and near-shore production opportunities for international customers.

North America growth The 2023 acquisition of Best Formulations strengthens Sirio's manufacturing capabilities and presence in North America, creating a compelling avenue for US and Canadian brands seeking scalable nutraceutical CDMO partnerships.

Eye health focus Recent launches and partnerships around eye-health soft chews and lutein formulations indicate a growing capability in visually supportive nutraceuticals, presenting cross-sell opportunities to brands in wellness, ophthalmic, and digital device users.

Microencapsulation Lubrizol collaboration to co-develop microencapsulated nutritional solutions highlights advanced delivery technology, enabling premium formulations and differentiating offerings for customers seeking stability, taste masking, and extended shelf life.

Public health partnerships Strategic partnerships with organizations like Vitamin Angels and participation in high-profile trade events position Sirio as a socially responsible supplier with access to health-focused channels and NGO-led nutrition programs for co-branded or impact-driven products.